Unaudited Condensed Consolidated Statements of Stockholders Investment - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jul. 31, 2021	Aug. 01, 2020	Jul. 31, 2021	Aug. 01, 2020
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance - beginning of period (in shares)				39,379,865
Balance-beginning of period		$ 439,466	$ 304,567	$ 391,036	$ 328,983
Net income		46,696	40,355	131,462	25,068
Issuance of shares through the Company's equity plans		226	95	1,997	261
Purchase of shares under the stock repurchase program		(83,164)	0	(120,477)	(9,748)
Settlement of net share equity awards		(331)	(59)	(3,178)	(483)
Dividends, Common Stock, Cash		(3,846)		(3,846)
Stock-based compensation		$ 1,131	$ 637	$ 3,183	$ 1,854
Balance - ending of period (in shares)		39,578,018	39,286,920	39,578,018	39,286,920
Balance-end of period		$ 400,179	$ 345,679	$ 400,179	$ 345,679
Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	[1]		$ 84		$ (256)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance - beginning of period (in shares)		39,559,000	39,255,000	39,380,000	39,141,000
Balance-beginning of period		$ 395	$ 393	$ 394	$ 391
Issuance of shares through the Company's equity plans (in shares)		19,000	32,000	198,000	146,000
Issuance of shares through the Company's equity plans		$ 1		$ 2	$ 2
Balance - ending of period (in shares)		39,578,000	39,287,000	39,578,000	39,287,000
Balance-end of period		$ 396	$ 393	$ 396	$ 393
Paid-In Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period		198,356	190,260	194,534	188,879
Issuance of shares through the Company's equity plans		225	95	1,995	259
Stock-based compensation		1,131	637	3,183	1,854
Balance-end of period		199,713	190,992	199,713	190,992
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period		943,718	769,315	858,951	784,942
Net income		46,696	40,355	131,462	25,068
Dividends, Common Stock, Cash		(3,846)		(3,846)
Balance-end of period		$ 986,568	809,754	$ 986,568	809,754
Retained Earnings | Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	[1]		$ 84		$ (256)
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance - beginning of period (in shares)		23,484,000	22,739,000	22,901,000	22,280,000
Balance-beginning of period		$ (703,003)	$ (655,401)	$ (662,843)	$ (645,229)
Purchase of shares under the stock repurchase program (in shares)		985,000		1,527,000	428,000
Purchase of shares under the stock repurchase program		$ (83,164)		$ (120,477)	$ (9,748)
Settlement of net share equity awards (in shares)		4,000	4,000	45,000	35,000
Settlement of net share equity awards		$ (331)	$ (59)	$ (3,178)	$ (483)
Balance - ending of period (in shares)		24,473,000	22,743,000	24,473,000	22,743,000
Balance-end of period		$ (786,498)	$ (655,460)	$ (786,498)	$ (655,460)

[1] Adoption of Accounting Standards Update ("ASU") No. 2016-13, Topic 326, Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments. See Note 2, Recent Accounting Pronouncements, in our Annual Report on Form 10-K filed on April 7, 2021.